Joel Francesqui

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Venues

Expert opinion on pharmacotherapy

ERJ open research

This page only lists publications with an associated author ORCID identifier.

Publications

María Caridad Mata Salvador, Joel Francesqui, Jacobo Sellarés
The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis. Expert opinion on pharmacotherapy (2024)
María Caridad Mata Salvador, Joel Francesqui, Jacobo Sellarés
The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis. Expert opinion on pharmacotherapy 25 (10) (2024)
Esteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia, Myriam Aburto, Jacobo Sellarés Torres, Joel Francesqui, Karina Portillo Carroz, Alan Jhunior Solis Solis, Orlando Acosta Fernández, Ana Belén Llanos González, Jaume Bordas-Martinez, Eva Cabrera Cesar, Eva Balcells Vilarnau, Diego Castillo, Ana Reyes Pardessus, Coral González Fernández, Marta García Moyano, Amaia Urrutia Gajate, Andrés Blanco Hortas, María Molina-Molina
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. ERJ open research 10 (1) (2024)
María Caridad Mata Salvador, Joel Francesqui, Jacobo Sellares
The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis. Expert opinion on pharmacotherapy (2024)
Esteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia, Myriam Aburto, Jacobo Sellarés Torres, Joel Francesqui, Karina Portillo Carroz, Alan Jhunior Solis Solis, Orlando Acosta Fernández, Ana Belén Llanos González, Jaume Bordas-Martinez, Eva Cabrera Cesar, Eva Balcells Vilarnau, Diego Castillo, Ana Reyes Pardessus, Coral González Fernández, Marta García Moyano, Amaia Urrutia Gajate, Andrés Blanco Hortas, María Molina-Molina
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. ERJ open research 10 (1) (2024)

Joel Francesqui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joel Francesqui